The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Innate or Adaptive Immunity? The Example of Natural Killer Cells
Open accessAbstract
Natural killer (NK) cells were originally defined as effector lymphocytes of innate immunity endowed with constitutive cytolytic functions. More recently, a more nuanced view of NK cells has emerged. NK cells are now recognized to express a repertoire of activating and inhibitory receptors that is calibrated to ensure self-tolerance while allowing efficacy against assaults such as viral infection and tumor development. Moreover, NK cells do not react in an invariant manner but rather adapt to their environment. Finally, recent studies have unveiled that NK cells can also mount a form of antigen-specific immunologic memory. NK cells thus exert sophisticated biological functions that are attributes of both innate and adaptive immunity, blurring the functional borders between these two arms of the immune response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Depending on the ligands expressed by the tumor cells studied, different NK-activating receptors may be engaged and trigger cytotoxicity (Vivier et al., 2011).”
From p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells (2013) · cites this paper as Vivier et al., 2011
In the citing paper
“Further analysis showed that the translocation of E. hirae to secondary lymphoid organs could exert an adjuvant impact on systemic and local immune responses mediated by CTX [2].”
From Gut microbiota-mediated immunomodulation in tumor (2021) · cites this paper as [2]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
Ruggeri, L., Capanni, M., Urbani, E., Perruccio, K., Shlomchik, W. D., Tosti, A., Posati, S., Rogaia, D., Frassoni, F., Aversa, F., et al. (2002) · Science · doi:10.1126/science.1068440 · Cited by 3,380
Lanier, L. L. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115526 · Cited by 2,765
Self-citationSelective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy
Kärre, K., Ljunggren, H., Piontek, G., & Kiessling, R. (1986) · Nature · doi:10.1038/319675a0 · Cited by 2,333
Caligiuri, M. A. (2008) · Blood · doi:10.1182/blood-2007-09-077438 · Cited by 1,980
Self-citationMiller, J. S., Soignier, Y., Panoskaltsis‐Mortari, A., McNearney, S. A., Yun, G. H., Fautsch, S. K., McKenna, D. H., Le, C. T., DeFor, T. E., Burns, L. J., et al. (2005) · Blood · doi:10.1182/blood-2004-07-2974 · Cited by 1,894
Kiessling, R. W., Klein, E., & Wigzell, H. (1975) · European Journal of Immunology · doi:10.1002/eji.1830050208 · Cited by 1,827
Activating Receptors and Coreceptors Involved in Human Natural Killer Cell-Mediated Cytolysis
Moretta, A., Bottino, C., Vitale, M., Pende, D., Cantoni, C., Mingari, M. C., Biassoni, R., & Moretta, L. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.197 · Cited by 1,773
Self-citationAdaptive Immune Features of Natural Killer Cells
Sun, J. C., Beilke, J., & Lanier, L. (2009) · Nature · doi:10.1038/nature07665 · Cited by 1,647
Self-citationHerberman, R. B., Nunn, M. E., & Lavrin, D. H. (1975) · International Journal of Cancer · doi:10.1002/ijc.2910160204 · Cited by 1,356
Induced recruitment of NK cells to lymph nodes provides IFN-γ for TH1 priming
Martin‐Fontecha, A., Thomsen, L. L., Brett, S. J., Gerard, C. J., Lipp, M., Lanzavecchia, A., & Sallusto, F. (2004) · Nature Immunology · doi:10.1038/ni1138 · Cited by 1,351
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 1,003
Schmohl, J., Gleason, M., Dougherty, P., Miller, J. S., & Vallera, D. A. (2015) · Targeted Oncology · doi:10.1007/s11523-015-0391-8 · Cited by 112
Single Degranulations in NK Cells Can Mediate Target Cell Killing
Gwalani, L. A., & Orange, J. S. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701500 · Cited by 112
Immunomodulating nano-adaptors potentiate antibody-based cancer immunotherapy
Jiang, C., Chen, K., Liu, A., Huang, H., Fan, Y.-N., Zhao, D., Ye, Q., Zhang, H., Xu, C., Shen, S., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21497-6 · Cited by 112
Sieni, E., Cetica, V., Hackmann, Y., Coniglio, M. L., Ros, M. D., Ciambotti, B., Pende, D., Griffiths, G. M., & Aricò, M. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00167 · Cited by 111
Gunda, V., Gigliotti, B. J., Ashry, T., Ndishabandi, D., McCarthy, M., Zhou, Z., Amin, S., Lee, K. E., Stork, T., Wirth, L. J., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.32041 · Cited by 112
Uppendahl, L. D., Felices, M., Bendzick, L. E., Ryan, C., Kodal, B., Hinderlie, P., Boylan, K. L. M., Skubitz, A. P. N., Miller, J. S., & Geller, M. A. (2019) · Gynecologic Oncology · doi:10.1016/j.ygyno.2019.01.006 · Cited by 117
The Immune Microenvironment of Breast Cancer Progression
Tower, H., Ruppert, M., & Britt, K. L. (2019) · Cancers · doi:10.3390/cancers11091375 · Cited by 119
Accumulation of natural killer cells in ischemic brain tissues and the chemotactic effect of IP-10
Zhang, Y., Gao, Z., Wang, D., Zhang, T., Sun, B., Mu, L., Wang, J., Liu, Y., Kong, Q., Liu, X., et al. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-79 · Cited by 111
Xu, H. C., Wang, X., Liu, D., Moroney‐Rasmussen, T., Lackner, A. A., & Veazey, R. S. (2012) · Mucosal Immunology · doi:10.1038/mi.2012.39 · Cited by 110
Edlich, B., Ahlenstiel, G., Zabaleta, A., Stoltzfus, J., Noureddin, M., Serti, E., Feld, J. J., Liang, J. T., Rotman, Y., & Rehermann, B. (2011) · Hepatology · doi:10.1002/hep.24628 · Cited by 110
Balsamo, M., Vermi, W., Parodi, M., Pietra, G., Manzini, C., Queirolo, P., Lonardi, S., Augugliaro, R., Moretta, A., Facchetti, F., et al. (2012) · European Journal of Immunology · doi:10.1002/eji.201142179 · Cited by 110
Self-citationNK Cells: Immune Cross-Talk and Therapeutic Implications
Malhotra, A., & Shanker, A. (2011) · Immunotherapy · doi:10.2217/imt.11.102 · Cited by 113
Tumor Necrosis Factor Superfamily in Innate Immunity and Inflammation
Šedý, J., Bekiaris, V., & Ware, C. F. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016279 · Cited by 109
Pahl, J. H. W., Ruslan, S. E. N., Buddingh, E. P., Santos, S. J., Szuhai, K., Serra, M., Gelderblom, H. A. J., Hogendoorn, P. C. W., Egeler, R. M., Schilham, M. W., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2277 · Cited by 111
NK cells: A double edge sword against SARS-CoV-2
Masselli, E., Vaccarezza, M., Carubbi, C., Pozzi, G., Presta, V., Mirandola, P., & Vitale, M. (2020) · Advances in Biological Regulation · doi:10.1016/j.jbior.2020.100737 · Cited by 110
Zheng, G., Guo, Z., Li, W., Xi, W., Zuo, B., Zhang, R., Wen, W., Yang, A., & Jia, L. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00629-w · Cited by 114
Liu, A.-J., Yu, J., Ji, H., Zhang, H.-C., Zhang, Y., & Liu, H. (2017) · Molecules · doi:10.3390/molecules23010062 · Cited by 108
Impaired intrahepatic natural killer cell cytotoxic function in chronic hepatitis C virus infection
Varchetta, S., Mele, D., Mantovani, S., Oliviero, B., Cremonesi, E., Ludovisi, S., Michelone, G., ALESSIANI, M., Rosati, R., Montorsi, M., et al. (2012) · Hepatology · doi:10.1002/hep.25723 · Cited by 109
Harnessing NK Cell Memory for Cancer Immunotherapy
Fehniger, T. A., & Cooper, M. A. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.09.005 · Cited by 106
Diversity of tissue-resident NK cells
Peng, H. C., & Tian, Z. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.07.006 · Cited by 113
HLA-G-mediated NK cell senescence promotes vascular remodeling: implications for reproduction
Rajagopalan, S. (2014) · Cellular and Molecular Immunology · doi:10.1038/cmi.2014.53 · Cited by 106
Natural killer cell–mediated inflammation resolution is disabled in severe asthma
Duvall, M. G., Barnig, C., Cernadas, M., Ricklefs, I., Krishnamoorthy, N., Grossman, N. L., Bhakta, N. R., Fahy, J. V., Bleecker, E. R., Castro, M., et al. (2017) · Science Immunology · doi:10.1126/sciimmunol.aam5446 · Cited by 109
Ishikawa, T., Okayama, T., Sakamoto, N., Ideno, M., Oka, K., Enoki, T., Mineno, J., Yoshida, N., Katada, K., Kamada, K., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31285 · Cited by 107
Qian, M., Chen, L., Du, Y., Jiang, H., Huo, T., Yang, Y., Guo, W., Wang, Y., & Huang, R. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b02448 · Cited by 106
When killers become thieves: Trogocytosed PD-1 inhibits NK cells in cancer
Hasim, M. S., Marotel, M., Hodgins, J. J., Vulpis, E., Makinson, O., Asif, S., Shih, H., Scheer, A. K., MacMillan, O., Alonso, F. G., et al. (2022) · Science Advances · doi:10.1126/sciadv.abj3286 · Cited by 113
Natural killer cells in inflammatory heart disease
Ong, S., Rose, N. R., & Čiháková, D. (2016) · Clinical Immunology · doi:10.1016/j.clim.2016.11.010 · Cited by 109
Natural Killer Cells: Tumor Surveillance and Signaling
Guzman, L. G. M., Keating, N., & Nicholson, S. E. (2020) · Cancers · doi:10.3390/cancers12040952 · Cited by 118
Dual Relationship Between Stromal Cells and Immune Cells in the Tumor Microenvironment
Mun, J.-Y., Leem, S., Lee, J. H., & Kim, H. S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.864739 · Cited by 113
Yiu, H., Graham, A. L., & Stengel, R. F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045027 · Cited by 104
Keppel, M. P., Yang, L., & Cooper, M. A. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201742 · Cited by 104
Bottos, A., Gotthardt, D., Gill, J. W., Gattelli, A., Frei, A., Tzankov, A., Sexl, V., Wodnar‐Filipowicz, A., & Hynes, N. E. (2016) · Nature Communications · doi:10.1038/ncomms12258 · Cited by 105
Shades of grey — the blurring view of innate and adaptive immunity
Lanier, L. L. (2013) · Nature reviews. Immunology · doi:10.1038/nri3389 · Cited by 106
Self-citationHow do we choose the best donor for T-cell-replete, HLA-haploidentical transplantation?
Chang, Y., Luznik, L., Fuchs, E. J., & Huang, X. (2016) · Journal of Hematology & Oncology · doi:10.1186/s13045-016-0265-2 · Cited by 103
Kim, J. H., Park, K., Lee, S. B., Kang, S., Park, J. S., Ahn, C. W., & Nam, J. S. (2019) · Journal of Diabetes Investigation · doi:10.1111/jdi.13002 · Cited by 107
Bellora, F., Castriconi, R., Dondero, A., Pessino, A. M., Nencioni, A., Liggieri, G., Moretta, L., Mantovani, A., Moretta, A., & Bottino, C. (2014) · European Journal of Immunology · doi:10.1002/eji.201344130 · Cited by 103
Self-citationCysteine Cathepsins as Regulators of the Cytotoxicity of NK and T Cells
Nanut, M. P., Sabotič, J., Jewett, A., & Kos, J. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00616 · Cited by 105
Iraolagoitia, X. L. R., Spallanzani, R. G., Torres, N. I., Araya, R. E., Ziblat, A., Domaica, C. I., Sierra, J. M., Núñez, S. Y., Secchiari, F., Gajewski, T. F., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502291 · Cited by 105
Preservation of cell-based immunotherapies for clinical trials
Li, R., Johnson, R., Yu, G., McKenna, D. H., & Hubel, A. (2019) · Cytotherapy · doi:10.1016/j.jcyt.2019.07.004 · Cited by 106
Immunomodulatory peptides—A promising source for novel functional food production and drug discovery
Pavlićević, M., Marmiroli, N., & Maestri, E. (2021) · Peptides · doi:10.1016/j.peptides.2021.170696 · Cited by 104
Bartel, Y., Bauer, B., & Steinle, A. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00362 · Cited by 109
Innate Immune Memory: Time for Adopting a Correct Terminology
Boraschi, D., & Italiani, P. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00799 · Cited by 108
Vito, C. D., Mikulak, J., Zaghi, E., Pesce, S., Marcenaro, E., & Mavilio, D. (2019) · Seminars in Immunology · doi:10.1016/j.smim.2019.03.004 · Cited by 104
Immune Cell-Derived Extracellular Vesicles – New Strategies in Cancer Immunotherapy
Yang, P., Peng, Y., Yuan, F., Xu, Z., Feng, P., Cao, J., Chen, Y., Chen, X., Cao, X., Yang, Y., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.771551 · Cited by 103
Amimo, J. O., Michael, H., Chepngeno, J., Raev, S. A., Saif, L. J., & Vlasova, A. N. (2022) · Nutrients · doi:10.3390/nu14235038 · Cited by 109
Šedý, J. R., Bjordahl, R., Bekiaris, V., Macauley, M. G., Ware, B. C., Norris, P. S., Lurain, N. S., Benedict, C. A., & Ware, C. F. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300894 · Cited by 99
Regulation of immune responses by E3 ubiquitin ligase Cbl-b
Tang, R., Langdon, W. Y., & Zhang, J. (2018) · Cellular Immunology · doi:10.1016/j.cellimm.2018.11.002 · Cited by 102
Toll‐Like Receptors in Natural Killer Cells and Their Application for Immunotherapy
Noh, J.-Y., Yoon, S. R., Kim, T., Choi, I., & Jung, H. (2020) · Journal of Immunology Research · doi:10.1155/2020/2045860 · Cited by 104
Deshpande, R. P., Sharma, S., & Watabe, K. (2020) · Cancers · doi:10.3390/cancers12102983 · Cited by 102
Coordinated Expression of DNAM-1 and LFA-1 in Educated NK Cells
Enqvist, M., Ask, E. H., Forslund, E., Carlsten, M., Abrahamsen, G., Béziat, V., Andersson, S., Schaffer, M., Spurkland, A., Bryceson, Y. T., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401972 · Cited by 100
Primary immunodeficiencies: A rapidly evolving story
Parvaneh, N., Casanova, J., Notarangelo, L. D., & Conley, M. E. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.11.051 · Cited by 102
Eguizábal, C., Zenarruzabeitia, O., Monge, J., Santos, S. D. M., Vesga, M. Á., Maruri, N., Arrieta, A., n, M. R., Tamayo-Orbegozo, E., Amo, L., et al. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00439 · Cited by 99
Cost of immune priming within generations: trade-off between infection and reproduction
Contreras-Garduño, J. A., Rodriguez, M. C., Rodriguez, M. H., Alvarado‐Delgado, A., & Lanz‐Mendoza, H. (2013) · Microbes and Infection · doi:10.1016/j.micinf.2013.11.010 · Cited by 99
IL-18 Drives ILC3 Proliferation and Promotes IL-22 Production via NF-κB
Victor, A. R., Nalin, A. P., Dong, W., McClory, S., Wei, M., Mao, C., Kladney, R. D., Youssef, Y., Chan, W. K., Briercheck, E. L., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601554 · Cited by 100
Self-citationInnate immunity, inflammation and tumour progression: double‐edged swords
Mantovani, A., Ponzetta, A., Inforzato, A., & Jaillon, S. (2019) · Journal of Internal Medicine · doi:10.1111/joim.12886 · Cited by 102
Liu, S., Zhang, Y., Liu, Y., Wang, W., Gao, S., Yuan, W., Sun, Z., Liu, L., & Wang, C. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-02076-y · Cited by 106
Systemic inflammation impairs respiratory chemoreflexes and plasticity
Huxtable, A. G., Vinit, S., Windelborn, J. A., Crader, S. M., Guenther, C. H., Watters, J. J., & Mitchell, G. S. (2011) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2011.06.017 · Cited by 99
Targeting Cancer Stem Cells with Natural Killer Cell Immunotherapy
Luna, J. I., Grossenbacher, S. K., Murphy, W. J., & Canter, R. J. (2016) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2017.1271874 · Cited by 99
Redefining Memory: Building the Case for Adaptive NK Cells
Paust, S., Blish, C. A., & Reeves, R. K. (2017) · Journal of Virology · doi:10.1128/jvi.00169-17 · Cited by 98
Morandi, F., Yazdanifar, M., Cocco, C., Bertaina, A., & Airoldi, I. (2020) · Cells · doi:10.3390/cells9081757 · Cited by 103
Granzin, M., Soltenborn, S., Müller, S., Kollet, J., Berg, M., Cerwenka, A., Childs, R. W., & Huppert, V. (2015) · Cytotherapy · doi:10.1016/j.jcyt.2015.03.611 · Cited by 98
Rocca, Y. S., Roberti, M. P., Juliá, E. P., Pampena, M. B., Bruno, L., Rivero, S., Huertas, E., Sánchez Loria, F., Pairola, A., Caignard, A., et al. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00413 · Cited by 97
NK Cells and Cancer Immunoediting
Guillerey, C., & Smyth, M. J. (2015) · Current topics in microbiology and immunology · doi:10.1007/82_2015_446 · Cited by 97
Obesity: An Immunometabolic Perspective
Ray, I., Mahata, S. K., & De, R. K. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00157 · Cited by 107
The transcription factor Bcl11b promotes both canonical and adaptive NK cell differentiation
Holmes, T. D., Pandey, R. V., Helm, E. Y., Schlums, H., Han, H., Campbell, T. M., Drashansky, T. T., Chiang, S. C. C., Wu, C.-Y., Tao, C., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abc9801 · Cited by 100
Vallera, D. A., Zhang, B., Gleason, M., Oh, S., Weiner, L. M., Kaufman, D. S., McCullar, V., Miller, J. S., & Verneris, M. R. (2013) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2012.1329 · Cited by 97
Type 2 Innate Lymphocytes Actuate Immunity Against Tumours and Limit Cancer Metastasis
Saranchova, I., Han, J. S., Zaman, R., Arora, H., Huang, H., Fenninger, F., Choi, K. B., Munro, L., Pfeifer, C. G., Welch, I. D., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-20608-6 · Cited by 94
Mitrović, M., Arapović, J., Jordan, S., Fodil-Cornu, N., Ebert, S., Vidal, S. M., Krmpotić, A., Reddehase, M. J., & Jonjić, S. (2011) · Journal of Virology · doi:10.1128/jvi.06042-11 · Cited by 96
Takeda, K., Nakayama, M., Sakaki, M., Hayakawa, Y., Imawari, M., Ogasawara, K., Okumura, K., & Smyth, M. J. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.0411208 · Cited by 100
Activating killer cell immunoglobulin-like receptor 2DS2 binds to HLA-A*11
Liu, J., Xiao, Z., Ko, H. L., Shen, M., & Ren, E. C. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1322052111 · Cited by 98
NK cells require IL-28R for optimal in vivo activity
Souza-Fonseca-Guimarães, F., Young, A., Mittal, D., Martinet, L., Bruedigam, C., Takeda, K., Andoniou, C. E., Degli‐Esposti, M. A., Hill, G. R., & Smyth, M. J. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1424241112 · Cited by 95
Harnessing NK Cells for Cancer Treatment
Minetto, P., Guolo, F., Pesce, S., Greppi, M., Obino, V., Ferretti, E., Sivori, S., Genova, C., Lemoli, R. M., & Marcenaro, E. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02836 · Cited by 96
Childhood Obesity and Cancer Risk in Adulthood
Weihe, P., Spielmann, J., Kielstein, H., Klusmann, J., & Blüher, S. (2020) · Current Obesity Reports · doi:10.1007/s13679-020-00387-w · Cited by 96
Zalfa, C., & Paust, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.633205 · Cited by 100
Natural Killer Cell-Derived Extracellular Vesicles: Novel Players in Cancer Immunotherapy
Wu, F., Xie, M., Hun, M., She, Z., Li, C., Luo, S., Chen, X., Wan, W., Wen, C., & Tian, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.658698 · Cited by 96
Ebbo, M., Gérard, L., Carpentier, S., Vely, F., Cypowyj, S., Farnarier, C., Vince, N., Malphettes, M., Fieschi, C., Oksenhendler, É., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.02.025 · Cited by 96
Mutational and Antigenic Landscape in Tumor Progression and Cancer Immunotherapy
Vitale, I., Sistigu, A., Manic, G., Rudqvist, N.-P., Trajanoski, Z., & Galluzzi, L. (2019) · Trends in Cell Biology · doi:10.1016/j.tcb.2019.01.003 · Cited by 95
Zheng, C., Wang, Q., Wang, Y., Zhao, X., Gao, K., Liu, Q., Zhao, Y., Zhang, Z., Zheng, Y., Cao, J., et al. (2019) · Advanced Materials · doi:10.1002/adma.201902542 · Cited by 94
Quintarelli, C., Sivori, S., Caruso, S., Carlomagno, S., Falco, M., Boffa, I., Orlando, D., Guercio, M., Abbaszadeh, Z., Sinibaldi, M., et al. (2019) · Leukemia · doi:10.1038/s41375-019-0613-7 · Cited by 98
Sun, H., Shi, K., Qi, K., Kong, H., Zhang, J., Dai, S., Ye, W., Deng, T., He, Q., & Zhou, M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02819 · Cited by 94
RetractedNK cell–derived GM-CSF potentiates inflammatory arthritis and is negatively regulated by CIS
Louis, C., Souza-Fonseca-Guimarães, F., Yang, Y., D'Silva, D. B., Kratina, T., Dagley, L., Hediyeh-zadeh, S., Rautela, J., Masters, S., Davis, M., et al. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20191421 · Cited by 87
Decidual macrophages and their roles at the maternal-fetal interface.
Houser, B. L. (2012) · Europe PMC (PubMed Central) · Cited by 94
Human Lymphoid Tissues Harbor a Distinct CD69+CXCR6+ NK Cell Population
Lugthart, G., Melsen, J. E., Vervat, C., Dam, M. M. V. O.-T., Corver, W. E., Roelen, D. L., van Bergen, J., van Tol, M. J. D., Lankester, A. C., & Schilham, M. W. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502603 · Cited by 97
Böttger, E., Multhoff, G., Kun, J. F. J., & Esen, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033774 · Cited by 93
Emerging concepts in immunity to hepatitis C virus infection
Rosen, H. R. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67714 · Cited by 93
Li, T., Zhang, Q., Jiang, Y., Yu, J., Hu, Y., Mou, T., Chen, G., & Li, G. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1069936 · Cited by 94
Muccio, L., Bertaina, A., Falco, M., Pende, D., Meazza, R., López‐Botet, M., Moretta, L., Locatelli, F., Moretta, A., & Chiesa, M. D. (2015) · Haematologica · doi:10.3324/haematol.2015.134155 · Cited by 93
Self-citationPark, I. H., Yang, H. N., Lee, K. J., Kim, T.-S., Lee, E. S., Jung, S., Kwon, Y., & Kong, S. (2017) · Oncotarget · doi:10.18632/oncotarget.16281 · Cited by 93
Immunocyte Membrane-Coated Nanoparticles for Cancer Immunotherapy
Gong, P., Wang, Y., Zhang, P., Yang, Z., Deng, W., Sun, Z., Yang, M., Li, X., Ma, G., Deng, G., et al. (2020) · Cancers · doi:10.3390/cancers13010077 · Cited by 93
Cai, L., Liu, H., Huang, F., Fujimoto, J., Girard, L., Chen, J., Li, Y., Zhang, Y.-A., Deb, D., Stastny, V., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-01842-7 · Cited by 93
The Role of Natural Killer Cells in Sepsis
Chiche, L., Forel, J.-M., Thomas, G., Farnarier, C., Vely, F., Bléry, M., Papazian, L., & Vivier, É. (2011) · BioMed Research International · doi:10.1155/2011/986491 · Cited by 92
Harnessing Oncolytic Virus-mediated Antitumor Immunity in an Infected Cell Vaccine
Lemay, C. G., Rintoul, J. L., Kuś, A., Paterson, J. M., Garcia, V., Falls, T. J., Ferreira, L., Bridle, B. W., Conrad, D. P., Tang, V. A., et al. (2012) · Molecular Therapy · doi:10.1038/mt.2012.128 · Cited by 93
Dura, B., Servos, M. M., Barry, R. M., Ploegh, H. L., Dougan, S. K., & Joel Voldman, B. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1515364113 · Cited by 97
Brodbeck, T., Nehmann, N., Bethge, A., Wedemann, G., & Schumacher, U. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-244 · Cited by 92
Nelson, A., Mould, A. W., Bikoff, E. K., & Robertson, E. J. (2016) · Nature Communications · doi:10.1038/ncomms11414 · Cited by 94
Memory-Like NK Cells: Remembering a Previous Activation by Cytokines and NK Cell Receptors
Pahl, J. H. W., Cerwenka, A., & Ni, J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02796 · Cited by 99
PD-1 in human NK cells: evidence of cytoplasmic mRNA and protein expression
Mariotti, F. R., Petrini, S., Ingegnere, T., Tumino, N., Besi, F., Scordamaglia, F., Munari, E., Pesce, S., Marcenaro, E., Moretta, A., et al. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1557030 · Cited by 92
Self-citationTinker, A. V., Hirte, H. W., Provencher, D. M., Butler, M. O., Ritter, H. D., Tu, D., Azim, H. A., Paralejas, P., Grenier, N., Hahn, S.-A., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-0298 · Cited by 92
Cao, G., Wang, J., Zheng, X., Wei, H., Tian, Z., & Sun, R. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.674010 · Cited by 92
Expanded and Activated Natural Killer Cells for Immunotherapy of Hepatocellular Carcinoma
Kamiya, T., Chang, Y.-H., & Campana, D. (2016) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-15-0229 · Cited by 90
Koenig, A., Mezaache, S., Callemeyn, J., Barba, T., Mathias, V., Sicard, A., Charreau, B. L., Rabeyrin, M., Dijoud, F., Picard, C., et al. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020040433 · Cited by 91
Metadata
- Authors
- Vivier, E., Raulet, D. H., Moretta, A., Caligiuri, M. A., Zitvogel, L., Lanier, L. L., Yokoyama, W. M., & Ugolini, S.
- Affiliations
- Centre d’Immunologie de Marseille-Luminy (CIML), Université de la Méditerranée UM 631, Campus de Luminy, 13288 Marseille, France.
- University of California, Berkeley (US)
- University of Genoa (IT)
- The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (US)
- Inserm (FR)
- University of California, San Francisco (US)
- Howard Hughes Medical Institute (US)
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Raulet, David H.
- Moretta, Alessandro
- Caligiuri, Michael A.
- Zitvogel, Laurence
- Lanier, Lewis L.
- Yokoyama, Wayne M.
- Ugolini, Sophie
- ORCID
- Venue
- Science
- Published
- 2011-01-07
- Volume
- 331
- Issue
- 6013
- Pages
- 44-49
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC3089969
- OpenAlex
- W2146313292
- Cited by
- 2,824
- References
- 78
- Citations by year
- 2026: 133 · 2025: 147 · 2024: 158 · 2023: 142 · 2022: 215 · 2021: 211 · 2020: 222 · 2019: 205 · 2018: 176 · 2017: 211 · 2016: 176 · 2015: 191 · 2014: 199 · 2013: 200 · 2012: 150
- FWCI
- 17.62
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- HAL (submittedVersion)
- CINECA IRIS Institutial Research Information System (University of Genoa) (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Cancer Institute (R01CA093678, R01CA095137, P01CA095426, CA095137, CA16058, CA 68458, CA95426, CA093678, P30CA016058)
- National Institute of Allergy and Infectious Diseases (AI-068129, R01AI068129, AI51345, R37AI066897, AI039642, AI34385, R01AI033903, AI5716, R01AI051345, AI-33903, R01AI039642, AI066897, R01AI035021, AI035021, P30AI027763)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Keywords
- natural killer cells, innate immunity, adaptive immunity, NK cell receptors, activating and inhibitory receptors, self-tolerance, cytotoxicity, viral infection, antitumor immunity, immunological memory
- MeSH terms
- Animals, Humans, Immunity, Innate, Immunologic Memory, Killer Cells, Natural, Neoplasms, Receptors, Immunologic, Virus Diseases, Self Tolerance, Adaptive Immunity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
